Daily pill for lung cancer to be made routinely available on the NHS
According to Nice, osimertinib can help stop cancer from returning after surgery by targeting cells that have specific ...
Bullous Pemphigoid Market Set To Grow Substantially Through 2034, Delveinsight Projects
DelveInsight's“Bullous Pemphigoid Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Bullous Pemphigoid, historical and forecasted epidemiology as ...
Zacks.com on MSN5 小时
Incyte Gains 15.3% in a Year: Is There Room for Further Growth?
Shares of Incyte INCY have risen 15.3% in the past twelve months against the industry’s decline of 14.3%. The stock has ...
ophthalmologytimes9 小时
Glaukos announces several positive clinical updates for its iDose platform
The iDose platform is designed to address ubiquitous patient non-adherence and chronic side effects associated with topical medications by providing 24/7 release of medication.
Boston Scientific sees success in PFA device trial
US healthtech giant Boston Scientific’s pulmonary vein isolation (PVI) device trial has met its primary endpoint in patients ...
These Covid Symptoms Are Red Flags That You Need Medical Attention
But while many folks do improve at home thanks to a combination of medication, rest, hydration and time, others require ...